These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36828794)

  • 41. A physiologically based kinetic (PBK) model describing plasma concentrations of quercetin and its metabolites in rats.
    Boonpawa R; Spenkelink A; Rietjens IM; Punt A
    Biochem Pharmacol; 2014 May; 89(2):287-99. PubMed ID: 24561179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrochemical and in vitro neuronal recording characteristics of multi-electrode arrays surface-modified with electro-co-deposited gold-platinum nanoparticles.
    Kim YH; Kim AY; Kim GH; Han YH; Chung MA; Jung SD
    Biomed Microdevices; 2016 Feb; 18(1):14. PubMed ID: 26830410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fabrication of gold-calcium phosphate composite nanoparticles through coprecipitation mediated by amino-terminated polyethylene glycol.
    Nakamura M; Oyane A; Kuroiwa K; Kosuge H
    Colloids Surf B Biointerfaces; 2020 Oct; 194():111169. PubMed ID: 32554258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mitoxantrone-Loaded PEGylated Gold Nanocomplexes for Cancer Therapy.
    Yoon JH; Cho HJ; Jin HE; Maeng HJ
    J Nanosci Nanotechnol; 2019 Feb; 19(2):687-690. PubMed ID: 30360142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity.
    Strikwold M; Spenkelink B; Woutersen RA; Rietjens IMCM; Punt A
    Toxicol Sci; 2017 Jun; 157(2):365-376. PubMed ID: 28498972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gold nanoparticle distribution in advanced in vitro and ex vivo human placental barrier models.
    Aengenheister L; Dietrich D; Sadeghpour A; Manser P; Diener L; Wichser A; Karst U; Wick P; Buerki-Thurnherr T
    J Nanobiotechnology; 2018 Oct; 16(1):79. PubMed ID: 30309365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multi-functional core-shell Fe
    S R; M P
    Colloids Surf B Biointerfaces; 2019 Feb; 174():252-259. PubMed ID: 30469046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols.
    Strikwold M; Spenkelink B; de Haan LHJ; Woutersen RA; Punt A; Rietjens IMCM
    Arch Toxicol; 2017 May; 91(5):2119-2133. PubMed ID: 27815601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Systematic Review of Published Physiologically-based Kinetic Models and an Assessment of their Chemical Space Coverage.
    Thompson CV; Firman JW; Goldsmith MR; Grulke CM; Tan YM; Paini A; Penson PE; Sayre RR; Webb S; Madden JC
    Altern Lab Anim; 2021 Sep; 49(5):197-208. PubMed ID: 34836462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Noncovalent intracellular drug delivery of hydrophobic drugs on Au NPs.
    Doane T; Burda C
    Methods Mol Biol; 2013; 1025():251-60. PubMed ID: 23918343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro to in vivo extrapolation of effective dosimetry in developmental toxicity testing: Application of a generic PBK modelling approach.
    Fragki S; Piersma AH; Rorije E; Zeilmaker MJ
    Toxicol Appl Pharmacol; 2017 Oct; 332():109-120. PubMed ID: 28760446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physiologically based kinetic modeling of hesperidin metabolism and its use to predict in vivo effective doses in humans.
    Boonpawa R; Spenkelink A; Punt A; Rietjens IMCM
    Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28218440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a nanocomposite of PEG-curcumin-gold nanoparticles as a near-infrared photothermal agent: an in vitro and animal model investigation.
    Rahimi-Moghaddam F; Azarpira N; Sattarahmady N
    Lasers Med Sci; 2018 Nov; 33(8):1769-1779. PubMed ID: 29790012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tutorial on physiologically based kinetic modeling in molecular nutrition and food research.
    Rietjens IM; Louisse J; Punt A
    Mol Nutr Food Res; 2011 Jun; 55(6):941-56. PubMed ID: 21520492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Artificial neural network and particle swarm optimization for removal of methyl orange by gold nanoparticles loaded on activated carbon and Tamarisk.
    Ghaedi M; Ghaedi AM; Ansari A; Mohammadi F; Vafaei A
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Nov; 132():639-54. PubMed ID: 24892545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel testing strategy for prediction of rat biliary excretion of intravenously administered estradiol-17β glucuronide.
    Noorlander A; Fabian E; van Ravenzwaay B; Rietjens IMCM
    Arch Toxicol; 2021 Jan; 95(1):91-102. PubMed ID: 33159584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of PEGylated Gold Nanoparticles: In Vitro-In Vivo Correlation.
    Dubaj T; Kozics K; Sramkova M; Manova A; Bastús NG; Moriones OH; Kohl Y; Dusinska M; Runden-Pran E; Puntes V; Nelson A; Gabelova A; Simon P
    Nanomaterials (Basel); 2022 Feb; 12(3):. PubMed ID: 35159859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incorporating renal excretion via the OCT2 transporter in physiologically based kinetic modelling to predict in vivo kinetics of mepiquat in rat.
    Noorlander A; Wesseling S; Rietjens IMCM; van Ravenzwaay B
    Toxicol Lett; 2021 Jun; 343():34-43. PubMed ID: 33639197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery.
    Terentyuk GS; Maslyakova GN; Suleymanova LV; Khlebtsov BN; Kogan BY; Akchurin GG; Shantrocha AV; Maksimova IL; Khlebtsov NG; Tuchin VV
    J Biophotonics; 2009 May; 2(5):292-302. PubMed ID: 19434616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HOCl-Activated Aggregation of Gold Nanoparticles for Multimodality Therapy of Tumors.
    Liu D; Liu L; Liu F; Zhang M; Wei P; Yi T
    Adv Sci (Weinh); 2021 Sep; 8(17):e2100074. PubMed ID: 34235882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.